These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 27823887)

  • 1. Targeting Alzheimer's disease by investigating previously unexplored chemical space surrounding the cholinesterase inhibitor donepezil.
    van Greunen DG; Cordier W; Nell M; van der Westhuyzen C; Steenkamp V; Panayides JL; Riley DL
    Eur J Med Chem; 2017 Feb; 127():671-690. PubMed ID: 27823887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel N-benzylpiperidine carboxamide derivatives as potential cholinesterase inhibitors for the treatment of Alzheimer's disease.
    van Greunen DG; Johan van der Westhuizen C; Cordier W; Nell M; Stander A; Steenkamp V; Panayides JL; Riley DL
    Eur J Med Chem; 2019 Oct; 179():680-693. PubMed ID: 31280020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational modification of donepezil as multifunctional acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
    Wang ZM; Cai P; Liu QH; Xu DQ; Yang XL; Wu JJ; Kong LY; Wang XB
    Eur J Med Chem; 2016 Nov; 123():282-297. PubMed ID: 27484514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
    Lan JS; Zhang T; Liu Y; Yang J; Xie SS; Liu J; Miao ZY; Ding Y
    Eur J Med Chem; 2017 Jun; 133():184-196. PubMed ID: 28388521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of multi-target-directed ligands against Alzheimer's disease based on the fusion of donepezil and ebselen.
    Luo Z; Sheng J; Sun Y; Lu C; Yan J; Liu A; Luo HB; Huang L; Li X
    J Med Chem; 2013 Nov; 56(22):9089-99. PubMed ID: 24160297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donepezil hydrochloride: a treatment drug for Alzheimer's disease.
    Sugimoto H
    Chem Rec; 2001; 1(1):63-73. PubMed ID: 11893059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.
    Bolea I; Juárez-Jiménez J; de Los Ríos C; Chioua M; Pouplana R; Luque FJ; Unzeta M; Marco-Contelles J; Samadi A
    J Med Chem; 2011 Dec; 54(24):8251-70. PubMed ID: 22023459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids.
    Bautista-Aguilera OM; Esteban G; Chioua M; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Soriano E; Samadi A; Unzeta M; Marco-Contelles J
    Drug Des Devel Ther; 2014; 8():1893-910. PubMed ID: 25378907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donepezil-Based Central Acetylcholinesterase Inhibitors by Means of a "Bio-Oxidizable" Prodrug Strategy: Design, Synthesis, and in Vitro Biological Evaluation.
    Peauger L; Azzouz R; Gembus V; Ţînţaş ML; Sopková-de Oliveira Santos J; Bohn P; Papamicaël C; Levacher V
    J Med Chem; 2017 Jul; 60(13):5909-5926. PubMed ID: 28613859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of new donepezil analogues and investigation of their effects on cholinesterase enzymes.
    Sağlık BN; Ilgın S; Özkay Y
    Eur J Med Chem; 2016 Nov; 124():1026-1040. PubMed ID: 27783974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological activity of new donepezil-hydrazinonicotinamide hybrids.
    Zurek E; Szymański P; Mikiciuk-Olasik E
    Drug Res (Stuttg); 2013 Mar; 63(3):137-44. PubMed ID: 23447117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs.
    Kryger G; Silman I; Sussman JL
    Structure; 1999 Mar; 7(3):297-307. PubMed ID: 10368299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and pharmacological evaluation of donepezil-based agents as new cholinesterase/monoamine oxidase inhibitors for the potential application against Alzheimer's disease.
    Li F; Wang ZM; Wu JJ; Wang J; Xie SS; Lan JS; Xu W; Kong LY; Wang XB
    J Enzyme Inhib Med Chem; 2016; 31(sup3):41-53. PubMed ID: 27384289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, in-silico and biological evaluation of novel donepezil derivatives as multi-target-directed ligands for the treatment of Alzheimer's disease.
    Mishra CB; Kumari S; Manral A; Prakash A; Saini V; Lynn AM; Tiwari M
    Eur J Med Chem; 2017 Jan; 125():736-750. PubMed ID: 27721157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of novel donepezil-coumarin hybrids as multi-target agents for the treatment of Alzheimer's disease.
    Xie SS; Lan JS; Wang X; Wang ZM; Jiang N; Li F; Wu JJ; Wang J; Kong LY
    Bioorg Med Chem; 2016 Apr; 24(7):1528-39. PubMed ID: 26917219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and evaluation of novel feruloyl-donepezil hybrids as potential multitarget drugs for the treatment of Alzheimer's disease.
    Dias KS; de Paula CT; Dos Santos T; Souza IN; Boni MS; Guimarães MJ; da Silva FM; Castro NG; Neves GA; Veloso CC; Coelho MM; de Melo IS; Giusti FC; Giusti-Paiva A; da Silva ML; Dardenne LE; Guedes IA; Pruccoli L; Morroni F; Tarozzi A; Viegas C
    Eur J Med Chem; 2017 Apr; 130():440-457. PubMed ID: 28282613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of the binding site of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine in acetylcholinesterase by docking studies with the SYSDOC program.
    Pang YP; Kozikowski AP
    J Comput Aided Mol Des; 1994 Dec; 8(6):683-93. PubMed ID: 7738604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease.
    Li Q; He S; Chen Y; Feng F; Qu W; Sun H
    Eur J Med Chem; 2018 Oct; 158():463-477. PubMed ID: 30243151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donepezil + propargylamine + 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's disease.
    Wang L; Esteban G; Ojima M; Bautista-Aguilera OM; Inokuchi T; Moraleda I; Iriepa I; Samadi A; Youdim MB; Romero A; Soriano E; Herrero R; Fernández Fernández AP; Ricardo-Martínez-Murillo ; Marco-Contelles J; Unzeta M
    Eur J Med Chem; 2014 Jun; 80():543-61. PubMed ID: 24813882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and evaluation of indanone derivatives as acetylcholinesterase inhibitors and metal-chelating agents.
    Meng FC; Mao F; Shan WJ; Qin F; Huang L; Li XS
    Bioorg Med Chem Lett; 2012 Jul; 22(13):4462-6. PubMed ID: 22633691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.